US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 2.2650
  • -0.2550-10.12%
Close Nov 1 16:00 ET
  • 2.2650
  • 0.00000.00%
Post 20:02 ET
60.78MMarket Cap-737P/E (TTM)

About Syros Pharmaceuticals Company

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Company Profile

SymbolSYRS
Company NameSyros Pharmaceuticals
Listing DateJun 30, 2016
Issue Price12.50
Founded2011
CEOMr. Conley Chee
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address35 CambridgePark Drive,4th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02140-2325
Phone1-617-744-1340
Websitehttp://www.syros.com

Company Executives

  • Name
  • Position
  • Salary
  • Conley Chee
  • Director, President and Chief Executive Officer
  • 1.04M
  • Kristin Stephens
  • Chief Development Officer
  • --
  • Gerald E. Quirk
  • Chief Legal & Compliance Officer and Head of Business Development
  • --
  • Jason Haas
  • Chief Financial Officer and Principal Accounting Officer
  • 833.02K
  • Dr. David A. Roth, M.D.
  • Chief Medical Officer
  • 876.53K
  • Peter Wirth, J.D.
  • Chairman of the Board
  • 110.40K
  • Dr. Nancy A. Simonian,M.D.
  • Director
  • 1.44M
  • Dr. Srinivas Akkaraju, M.D.,PhD
  • Independent Director
  • 78.15K
  • Marsha H. Fanucci
  • Independent Director
  • 84.78K
  • Andrew M. Oh
  • Independent Director
  • 78.53K
  • Dr. Sue Gail Eckhardt, M.D.
  • Independent Director
  • 82.40K
  • Dr. Deborah L. Dunsire,M.D.
  • Independent Director
  • 79.07K
  • Timothy C. Tyson
  • Independent Director
  • 76.03K
  • Dr. Richard A. Young,PhD
  • Independent Director
  • 82.15K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data